Publications dans lesquelles il/elle collabore avec J. Eugenio Sanchez Criado (9)

2006

  1. Oestradiol-17β inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat

    Journal of Endocrinology, Vol. 190, Núm. 1, pp. 73-84

  2. The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies

    Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139

2003

  1. Tamoxifen induces gonadotropin-releasing hormone self-priming through an estrogen-dependent progesterone receptor expression in the gonadotrope of the rat

    Neuroendocrinology, Vol. 77, Núm. 6, pp. 425-435

2002

  1. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat

    Neuroendocrinology, Vol. 76, Núm. 4, pp. 203-213

2000

  1. Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: Differential effect of two selective estrogen receptor modulators

    Neuroscience Letters, Vol. 289, Núm. 2, pp. 111-114

1999

  1. Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat

    Journal of Neuroendocrinology, Vol. 11, Núm. 10, pp. 785-794

1998

  1. Effect of RU486 injected on proestrous morning on LHRH, LH and 17β-estradiol secretion during the estrous cycle in rat

    Journal of Physiology and Biochemistry, Vol. 54, Núm. 2, pp. 91-98

1994

  1. Periovulatory LHRH, LH and FSH secretion in cyclic rats treated with RU486: Effects of exogenous LHRH and LHRH antagonist on LH and FSH secretion at early oestrus

    Journal of Endocrinology, Vol. 141, Núm. 1, pp. 7-14

1989

  1. Body growth and puberty remain unchanged in female rats after daily treatment with GRF (1-29) NH2

    Endocrinologia, Vol. 36, Núm. 1, pp. 3-6